BusinessBioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business DevelopmentBy Nasdaq OMXMar 13, 2018, 10:16 PM UTC
BusinessBioStem Technologies Inc. Applies for Uplisting to the OTCQX MarketBy Nasdaq OMXFeb 16, 2018, 2:44 PM UTC
BusinessBioStem Technologies, Inc. Announces the Addition of University of Miami Professor Brant D. Watson, Ph.D., to the Company’s Scientific Advisory BoardBy Nasdaq OMXDec 1, 2017, 8:05 PM UTC
